ELEV
Elevation Oncology Inc
North American company
Right Arrow 1
Healthcare
Right Arrow 2
Biotechnology
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Research
News & analysis
Loading...
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
Prev. Close
/
Mkt. Open
- / -
Volume
-
52w Low / High
- / -
Market Cap
-
P/E Ratio
-
Div. Yield
-
Company Profile
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.
Symbol
NASDAQ:ELEV
ISIN
US28623U1016
Currency
USD
Loading...
Loading Comparison
Latest ELEV News